← Back to Search

Diagnostic Device

FDT visual field for Glaucoma

N/A
Waitlist Available
Led By Richard Lee, MD, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult patients (18 and over) who speak English, Spanish or Creole, and are capable of providing informed consent and who have a Humphrey Visual Field (HVF) test within the prior the 6 months preceding enrollment are eligible for enrollment in this non-invasive study. Patients will be recruited from among patients at the Bascom Palmer Eye Institute clinics during their regularly scheduled clinic visits. No advertising will be used to recruit patients.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the investigators anticipate to enroll the subjects over a period of 12 months. the estimated time required for data analysis is 6 months following enrollment of all subjects.
Awards & highlights

Study Summary

This trial will compare two types of eye exams to see which is more effective. 500 patients will be enrolled.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the investigators anticipate to enroll the subjects over a period of 12 months. the estimated time required for data analysis is 6 months following enrollment of all subjects.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the investigators anticipate to enroll the subjects over a period of 12 months. the estimated time required for data analysis is 6 months following enrollment of all subjects. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pattern of visual field loss in FDT visual fields as compared with standard HVF
Secondary outcome measures
Mean deviation (MD) in FDT visual fields as compared with standard HVF
Pattern standard deviation (PSD) in FDT visual fields as compared with standard HVF

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment2 Interventions
FDT visual field will be compared to standard HVF in detecting glaucomatous visual field loss

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
904 Previous Clinical Trials
409,730 Total Patients Enrolled
10 Trials studying Glaucoma
2,022 Patients Enrolled for Glaucoma
Richard Lee, MD, PhDPrincipal InvestigatorUniversity of Miami / Bascom Palmer Eye Institute
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Journal of GlaucomaJournal
Predictive Value of Frequency Doubling Technology Perimetry for Detecting Glaucoma in a Developing Country
Mansberger, Steven L, Chris A Johnson, George A Cioffi, Dongseok Choi, S R Krishnadas, M Srinivasan, V Balamurugan, et al.. 2005. “Predictive Value of Frequency Doubling Technology Perimetry for Detecting Glaucoma in a Developing Country”. Journal of Glaucoma. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/01.ijg.0000151883.07232.54.
Journal of GlaucomaJournal
Detectability of Glaucomatous Changes Using SAP, FDT, Flicker Perimetry, and OCT
Nomoto, Hiroki, Chota Matsumoto, Sonoko Takada, Shigeki Hashimoto, Eiko Arimura, Sachiko Okuyama, and Yoshikazu Shimomura. 2009. “Detectability of Glaucomatous Changes Using SAP, FDT, Flicker Perimetry, and OCT”. Journal of Glaucoma. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/ijg.0b013e318179f7ca.
PediatricsJournal
Vision Screening for Children 1 to 5 Years of Age: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force. 2011. “Vision Screening for Children 1 to 5 Years of Age: US Preventive Services Task Force Recommendation Statement”. Pediatrics. American Academy of Pediatrics (AAP). doi:10.1542/peds.2010-3177.
Annals of Internal MedicineJournal
Screening for Glaucoma: U.S. Preventive Services Task Force Recommendation Statement
“Screening for Glaucoma: U.S. Preventive Services Task Force Recommendation Statement”. 2013. “Screening for Glaucoma: U.S. Preventive Services Task Force Recommendation Statement”. Annals of Internal Medicine. American College of Physicians. doi:10.7326/0003-4819-159-6-201309170-00686.
~57 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top